Abstract:BACKGROUND: Bone morphogenetic proteins (BMPs) are a group of cancer-related proteins vital for development and progression of certain cancer types. Nevertheless, function of BMP family in pan-cancer was not detailedly researched. OBJECTIVE: Investigating expression pattern and prognostic value of the BMPs family (BMP1-8A and BMP8B) expression across multiple cancer types. METHODS: Our research integrated multi-omics data for exploring potential associations between BMPs expression and prognosis, clinicopathological characteristics, copy number or somatic mutations, immune characteristics, tumor microenvironment (TME), tumor mutation burden (TMB), microsatellite instability (MSI), immune checkpoint genes and drug sensitivity in The Cancer Genome Atlas (TCGA) tumors. Furthermore, association of BMPs expression and immunotherapy effectiveness was investigated in some confirmatory cohorts (GSE111636, GSE78220, GSE67501, GSE176307, IMvigor210 and mRNA sequencing data from currently undergoing TRUCE01 clinical research included), and biological function and potential signaling pathways of BMPs in bladder cancer (BCa) was explored via Gene Set Enrichment Analysis (GSEA). Eventually, immune infiltration analysis was done via BMPs expression, copy number or somatic mutations in BCa, as well as validation of the expression levels by reverse transcription-quantitative PCR and western blot, and in vitro functional experiments of BMP8A. RESULTS: Discoveries displayed BMPs expression was related to prognosis, clinicopathological characteristics, mutations, TME, TMB, MSI and immune checkpoint genes of TCGA tumors. Anticancer drug sensitivity analysis displayed BMPs were associated with various drug sensitivities. What's more, it was discovered that expression level of certain BMP family members related to objective response to immunotherapy. By GSEA, we discovered multiple immune-associated functions and pathways were enriched. Immune infiltration analysis on BCa also displayed significant associations among BMPs copy number variations, mutation status and infiltration level of diverse immune cells. Furthermore, differential expression validation and in vitro phenotypic experiment indicated that BMP8A significantly promoted BCa cell proliferation, migration and invasion. CONCLUSIONS: Current results confirmed significance of both BMPs expression and genomic alteration in the prognosis and treatment of diverse cancer types, and suggested that BMPs may be vital for BCa and can possibly be utilized as biomarkers for immunotherapy.

Pan-cancer Transcriptomic Data of ABI1 Transcript Variants and Molecular Constitutive Elements Identifies Novel Cancer Metastatic and Prognostic Biomarkers.

The Roles and Prognostic Significance of ABI1-TSV-11 Expression in Patients with Left-Sided Colorectal Cancer.

Biomarker Discovery To Improve Prediction Of Breast Cancer Survival: Using Gene Expression Profiling, Meta-Analysis, And Tissue Validation

Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated with Thyroid Cancer Prognosis in the Tumor Micro-Environment

The relationship between ABI1 upregulation and clinicopathological features and prognosis of colorectal adenocarcinoma

Establishment of quantitative nested-PCR of Abelson interactor 1 transcript variant-11

ITGB1-DT/ARNTL2 axis may be a novel biomarker in lung adenocarcinoma: a bioinformatics analysis and experimental validation

Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker

Alternative Polyadenylation Modification Patterns Reveal Essential Posttranscription Regulatory Mechanisms of Tumorigenesis in Multiple Tumor Types.

The association between long noncoding RNA ABHD11-AS1 and malignancy prognosis: a meta-analysis

EBNA1BP2 identified as potential prognostic biomarker for multiple tumor types in pan-cancer analysis

BCAT1 : A risk factor in multiple cancers based on a pan‐cancer analysis

The prognostic significance and immune characteristics of bone morphogenetic proteins (BMPs) family: A pan-cancer multi-omics analysis

Pan-Cancer Analysis of PTBP1 to Identify it as a Prognostic and Immunological Biomarker

Identification of intratumor bacteria-associated prognostic risk score in adrenocortical carcinoma

Mining the Prognostic Significance and Immune Infiltration of STAT Family Members in Human Breast Cancer by Bioinformatics Analysis

Comprehensive Analysis Identifies Ameloblastin-Related Competitive Endogenous RNA as a Prognostic Biomarker for Testicular Germ Cell Tumour

Bone morphogenetic protein 1: a prognostic indicator and potential biomarker in three cancer types

Novel RNA-Affinity Proteogenomics Dissects Tumor Heterogeneity for Revealing Personalized Markers in Precision Prognosis of Cancer

Identify BCAT1 plays an oncogenic role and promotes EMT in KIRC via single cell RNA-seq and experiment

Abi1 Loss Drives Prostate Tumorigenesis Through Activation of EMT and Noncanonical WNT Signaling.